Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,072 | 61,005 | 33,627 | 40,426 | 50,843 |
| Marketable Securities | 267,057 | 196,355 | 109,786 | 100,914 | 92,337 |
| Receivables | 26,367 | 28,780 | 17,601 | 20,268 | 16,331 |
| Inventories | 1,140 | 994 | 840 | 779 | 1,294 |
| TOTAL | $354,136 | $299,132 | $169,857 | $174,175 | $166,547 |
| Non-Current Assets | |||||
| PPE Net | 3,864 | 4,417 | 5,306 | 5,015 | 4,570 |
| Intangibles | 23,037 | 24,542 | 26,069 | 27,819 | 38,752 |
| Other Non-Current Assets | 102,711 | 4,039 | 4,193 | 3,365 | 3,181 |
| TOTAL | $129,612 | $32,998 | $35,568 | $36,199 | $46,503 |
| Total Assets | $483,748 | $332,130 | $205,425 | $210,374 | $213,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 27,590 | 21,584 | 20,335 | 16,196 | 15,767 |
| Accrued Expenses | 31,915 | 31,231 | 23,028 | 34,124 | 35,550 |
| Other current liabilities | N/A | 200 | 27,000 | N/A | N/A |
| TOTAL | $59,505 | $53,015 | $70,363 | $50,320 | $51,317 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,298 | 3,693 | 3,675 | 28,724 | 28,706 |
| TOTAL | $13,298 | $3,693 | $3,675 | $28,724 | $28,706 |
| Total Liabilities | $72,803 | $56,708 | $74,038 | $79,044 | $80,023 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,649 | 52,643 | 45,438 | 44,346 | 43,103 |
| Common Shares | 54 | 52 | 45 | 44 | 43 |
| Retained earnings | -220,665 | -336,218 | -361,426 | -345,859 | -327,849 |
| Other shareholders' equity | 249 | 1 | -34 | 58 | 39 |
| TOTAL | $410,945 | $275,422 | $131,387 | $131,330 | $133,027 |
| Total Liabilities And Equity | $483,748 | $332,130 | $205,425 | $210,374 | $213,050 |